Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8784886 | Advances in Radiation Oncology | 2018 | 19 Pages |
Abstract
Patient compliance with pentoxifylline appears to be worse in clinical practice compared with previously published studies. Nausea was the most frequently reported indication for treatment modification or discontinuation. Concurrent antiemetic therapy was correlated with strong regimen compliance, but concurrent PPI therapy was correlated with poor compliance, independent of comorbid conditions.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Justin M. MD, Brady BS, Ali PharmD MS, Victor J. MD,